Dermatitis News

Dermatologists should be on the lookout for new forms of a highly contagious fungal infection now being reported in the U.S., according to a press release from NYU Langone Health.

Higher dietary sodium intake was associated with a higher risk for current atopic dermatitis, suggesting that a sodium-restricting diet may be a helpful intervention for disease management, according to a study.

Due to medical advancements, researchers are calling for an update to the U.S. Department of Defense’s policies restricting individuals with psoriasis and atopic dermatitis from joining and remaining in the military, according to a study.

Adults treated with amlitelimab showed sustained improvement in their moderate to severe atopic dermatitis over the span of 28 weeks, Sanofi announced in a press release.

The FDA has cleared InnoCare Pharma’s investigational new drug application for ICP-332, according to a press release.

The FDA has approved a single-dose autoinjector for Adbry, LEO Pharma announced in a press release.

Roflumilast cream 0.15% demonstrated long-term efficacy and tolerability in adults and children aged 6 years and older with atopic dermatitis, Arcutis announced in a press release.

Both organic and inorganic pigments used in cosmetic tattoos, also known as permanent makeup, may cause allergic contact dermatitis, according to a study.

CLEVELAND — For patients with atopic dermatitis, today’s systemic therapies can lead to long-standing on-drug relief, but long-term, off-drug remission remains a goal that has yet to be reached, according to Raj Chovatiya, MD, PhD.

CLEVELAND — For patients with chronic spontaneous urticaria, lab testing can help to phenotype disease and guide treatment, according to James Fernandez, MD, PhD, an allergy and immunology specialist at the Cleveland Clinic.